Alnylam Pharmaceuticals
ALNY
#630
Rank
$32.49 B
Marketcap
$251.00
Share price
0.20%
Change (1 day)
67.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company